UK markets closed

Citius Pharmaceuticals, Inc. (CTXR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7465+0.0545 (+7.88%)
As of 01:44PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.05-0.05-0.210.12
Low estimate-0.06-0.05-0.210.09
High estimate-0.05-0.05-0.210.16
Year ago EPS-0.07-0.06-0.22-0.21
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3332
Avg. Estimate14.81M15.43M61.72M83.59M
Low estimateN/AN/AN/A45.89M
High estimate44.44M46.29M185.17M121.3M
Year ago salesN/AN/AN/A61.72M
Sales growth (year/est)N/AN/AN/A35.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.03-0.05-0.020.13
Actual EPS-0.07-0.06-0.07-0.06
Difference-0.04-0.01-0.05-0.19
Surprise %-133.30%-20.00%-250.00%-146.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.05-0.05-0.210.12
7 days ago-0.05-0.05-0.210.12
30 days ago-0.05-0.05-0.210.12
60 days ago-0.05-0.05-0.210.12
90 days ago0.260.150.030.35
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCTXRIndustrySector(s)S&P 500
Current qtr.28.60%N/AN/AN/A
Next qtr.16.70%N/AN/AN/A
Current year4.50%N/AN/AN/A
Next year157.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A